title: A case of overlap syndrome successfully treated with tocilizumab: a hopeful treatment strategy for refractory dermatomyositis?
authors.affiliation: Department of Rheumatology and Department of Neurology, Faculty of Medicine, Shimane University, Shimane, Japan. mkondo@med.shimane-u.ac.jp.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kondo
authors.affiliation: Department of Rheumatology and Department of Neurology, Faculty of Medicine, Shimane University, Shimane, Japan.
authors.forename: Yohko
authors.initials: Y
authors.lastname: Murakawa
authors.affiliation: Department of Rheumatology and Department of Neurology, Faculty of Medicine, Shimane University, Shimane, Japan.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Matsumura
authors.affiliation: Department of Rheumatology and Department of Neurology, Faculty of Medicine, Shimane University, Shimane, Japan.
authors.forename: Osamu
authors.initials: O
authors.lastname: Matsumoto
authors.affiliation: Department of Rheumatology and Department of Neurology, Faculty of Medicine, Shimane University, Shimane, Japan.
authors.forename: Mariko
authors.initials: M
authors.lastname: Taira
authors.affiliation: Department of Rheumatology and Department of Neurology, Faculty of Medicine, Shimane University, Shimane, Japan.
authors.forename: Mayuko
authors.initials: M
authors.lastname: Moriyama
authors.affiliation: Department of Rheumatology and Department of Neurology, Faculty of Medicine, Shimane University, Shimane, Japan.
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Sumita
authors.affiliation: Department of Rheumatology and Department of Neurology, Faculty of Medicine, Shimane University, Shimane, Japan.
authors.forename: Shuhei
authors.initials: S
authors.lastname: Yamaguchi
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D003882:Dermatomyositis / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab